315 related articles for article (PubMed ID: 33401386)
1. Type IA Topoisomerases as Targets for Infectious Disease Treatments.
Seddek A; Annamalai T; Tse-Dinh YC
Microorganisms; 2021 Jan; 9(1):. PubMed ID: 33401386
[TBL] [Abstract][Full Text] [Related]
2. Exploring DNA topoisomerases as targets of novel therapeutic agents in the treatment of infectious diseases.
Tse-Dinh YC
Infect Disord Drug Targets; 2007 Mar; 7(1):3-9. PubMed ID: 17346206
[TBL] [Abstract][Full Text] [Related]
3. What's on the Other Side of the Gate: A Structural Perspective on DNA Gate Opening of Type IA and IIA DNA Topoisomerases.
Vidmar V; Vayssières M; Lamour V
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835394
[TBL] [Abstract][Full Text] [Related]
4. Variation of Structure and Cellular Functions of Type IA Topoisomerases across the Tree of Life.
Tan K; Tse-Dinh YC
Cells; 2024 Mar; 13(6):. PubMed ID: 38534397
[TBL] [Abstract][Full Text] [Related]
5. DNA Topoisomerases as Targets for Antibacterial Agents.
Hiasa H
Methods Mol Biol; 2018; 1703():47-62. PubMed ID: 29177732
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of Zn(II) binding type IA topoisomerases by organomercury compounds and Hg(II).
Cheng B; Annamalai T; Sandhaus S; Bansod P; Tse-Dinh YC
PLoS One; 2015; 10(3):e0120022. PubMed ID: 25798600
[TBL] [Abstract][Full Text] [Related]
7. Targeting bacterial topoisomerases: how to counter mechanisms of resistance.
Tse-Dinh YC
Future Med Chem; 2016 Jun; 8(10):1085-100. PubMed ID: 27285067
[TBL] [Abstract][Full Text] [Related]
8. Excision repair of topoisomerase DNA-protein crosslinks (TOP-DPC).
Sun Y; Saha S; Wang W; Saha LK; Huang SN; Pommier Y
DNA Repair (Amst); 2020 May; 89():102837. PubMed ID: 32200233
[TBL] [Abstract][Full Text] [Related]
9. DNA Topoisomerases of Kinetoplastid Parasites: Brief Overview and Recent Perspectives.
Saha S; Chowdhury SR; Majumder HK
Curr Issues Mol Biol; 2019; 31():45-62. PubMed ID: 31165719
[TBL] [Abstract][Full Text] [Related]
10. Telling Your Right Hand from Your Left: The Effects of DNA Supercoil Handedness on the Actions of Type II Topoisomerases.
Jian JY; Osheroff N
Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446377
[TBL] [Abstract][Full Text] [Related]
11. Crystal structure of a complex of a type IA DNA topoisomerase with a single-stranded DNA molecule.
Changela A; DiGate RJ; Mondragón A
Nature; 2001 Jun; 411(6841):1077-81. PubMed ID: 11429611
[TBL] [Abstract][Full Text] [Related]
12. Crystal structure of a covalent intermediate in DNA cleavage and rejoining by Escherichia coli DNA topoisomerase I.
Zhang Z; Cheng B; Tse-Dinh YC
Proc Natl Acad Sci U S A; 2011 Apr; 108(17):6939-44. PubMed ID: 21482796
[TBL] [Abstract][Full Text] [Related]
13. DNA Topoisomerases.
Bush NG; Evans-Roberts K; Maxwell A
EcoSal Plus; 2015; 6(2):. PubMed ID: 26435256
[TBL] [Abstract][Full Text] [Related]
14. SUMO: A Swiss Army Knife for Eukaryotic Topoisomerases.
Sun Y; Nitiss JL; Pommier Y
Front Mol Biosci; 2022; 9():871161. PubMed ID: 35463961
[TBL] [Abstract][Full Text] [Related]
15. Oligonucleotide-Recognizing Topoisomerase Inhibitors (OTIs): Precision Gene Editors for Neurodegenerative Diseases?
Bax BD; Sutormin D; McDonald NQ; Burley GA; Shelkovnikova T
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232843
[TBL] [Abstract][Full Text] [Related]
16. Targeting bacterial topoisomerase I to meet the challenge of finding new antibiotics.
Tse-Dinh YC
Future Med Chem; 2015; 7(4):459-71. PubMed ID: 25875873
[TBL] [Abstract][Full Text] [Related]
17. [Poisons of DNA topoisomerases I and II].
Charcosset JY; Soues S; Laval F
Bull Cancer; 1993 Nov; 80(11):923-54. PubMed ID: 8081034
[TBL] [Abstract][Full Text] [Related]
18. Recent advancements in the medicinal chemistry of bacterial type II topoisomerase inhibitors.
Jaswal S; Nehra B; Kumar S; Monga V
Bioorg Chem; 2020 Nov; 104():104266. PubMed ID: 33142421
[TBL] [Abstract][Full Text] [Related]
19. DNA topoisomerase-targeting chemotherapeutics: what's new?
Cuya SM; Bjornsti MA; van Waardenburg RCAM
Cancer Chemother Pharmacol; 2017 Jul; 80(1):1-14. PubMed ID: 28528358
[TBL] [Abstract][Full Text] [Related]
20. Compounds with antibacterial activity that enhance DNA cleavage by bacterial DNA topoisomerase I.
Cheng B; Liu IF; Tse-Dinh YC
J Antimicrob Chemother; 2007 Apr; 59(4):640-5. PubMed ID: 17317696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
